| __timestamp | PTC Therapeutics, Inc. | Pfizer Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 44820000 | 14097000000 |
| Thursday, January 1, 2015 | 82080000 | 14809000000 |
| Friday, January 1, 2016 | 97130000 | 14837000000 |
| Sunday, January 1, 2017 | 121271000 | 14784000000 |
| Monday, January 1, 2018 | 153548000 | 14455000000 |
| Tuesday, January 1, 2019 | 202541000 | 14350000000 |
| Wednesday, January 1, 2020 | 245164000 | 11615000000 |
| Friday, January 1, 2021 | 285773000 | 12703000000 |
| Saturday, January 1, 2022 | 325998000 | 13677000000 |
| Sunday, January 1, 2023 | 332540000 | 14771000000 |
| Monday, January 1, 2024 | 14730000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical industry, operational efficiency is key. Over the past decade, Pfizer Inc. and PTC Therapeutics, Inc. have showcased contrasting trends in their Selling, General, and Administrative (SG&A) expenses. Pfizer, a global giant, consistently reported SG&A expenses averaging around $14 billion annually, with a notable dip in 2020 to $11.6 billion, likely due to pandemic-related operational shifts. In contrast, PTC Therapeutics, a smaller biotech firm, saw its SG&A expenses grow by over 600% from 2014 to 2023, reflecting its aggressive expansion and development strategies. By 2023, PTC's SG&A expenses reached approximately $332 million, a significant leap from $44 million in 2014. This comparison highlights the diverse financial strategies within the pharmaceutical sector, where scale and growth ambitions dictate operational spending.
Cost Management Insights: SG&A Expenses for AbbVie Inc. and Pfizer Inc.
Selling, General, and Administrative Costs: Pfizer Inc. vs GSK plc
Selling, General, and Administrative Costs: Pfizer Inc. vs Axsome Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Pfizer Inc. or Catalyst Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Pfizer Inc. and MannKind Corporation
Selling, General, and Administrative Costs: Pfizer Inc. vs Mesoblast Limited
Breaking Down SG&A Expenses: Pfizer Inc. vs Dynavax Technologies Corporation
SG&A Efficiency Analysis: Comparing Blueprint Medicines Corporation and PTC Therapeutics, Inc.
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
PTC Therapeutics, Inc. vs Merus N.V.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for PTC Therapeutics, Inc. and Agios Pharmaceuticals, Inc.